Low levels of HIV-1 envelope-mediated fusion are associated with long-term survival of an infected CCR5-/- patient
Paul R Gorry, Fahim Ahmad, Jon Mohl, Ghalib Alkhatib
AIDS | LIPPINCOTT WILLIAMS & WILKINS | Published : 2018
Awarded by NIH
We thank Dr Chris Broder for providing T50 and other monoclonal antibodies to the gp120 protein. Special thanks go to Andy Grass, Viswanathan Rajagopalan, Troy Camarata, and Carol Brenner for excellent comments. The following reagents were obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH: T20, Fusion Inhibitor from AIDS, NIAID; HIV-1 gp160 Antiserum (HT7); 3T3. T4, 3T3. T4. CXCR4, and 3T3. T4. CCR5 from Dr Dan Littman. This work was supported by a NIH grant # AI052019 awarded to GA.This work was supported by a NIH grant # AI052019 awarded to GA.